TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma ; volume:13 ; number:1 ; day:27 ; month:9 ; year:2022 ; pages:1-18 ; date:12.2022
Nature Communications ; 13, Heft 1 (27.9.2022), 1-18, 12.2022
- Creator
-
Erazo, Tatiana
Evans, Chiara M.
Zakheim, Daniel
Chu, Karen L.
Refermat, Alice Yunsi
Asgari, Zahra
Yang, Xuejing
Silva Ferreira, Mariana Da
Mehta, Sanjoy
Russo, Marco Vincenzo
Knezevic, Andrea
Zhang, Xi-Ping
Chen, Zhengming
Fennell, Myles
Garippa, Ralph
Seshan, Venkatraman
Stanchina, Elisa de
Barbash, Olena
Batlevi, Connie Lee
Leslie, Christina S.
Melnick, Ari M.
Younes, Anas
Kharas, Michael G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-33137-8
- URN
-
urn:nbn:de:101:1-2022121521130738070144
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Erazo, Tatiana
- Evans, Chiara M.
- Zakheim, Daniel
- Chu, Karen L.
- Refermat, Alice Yunsi
- Asgari, Zahra
- Yang, Xuejing
- Silva Ferreira, Mariana Da
- Mehta, Sanjoy
- Russo, Marco Vincenzo
- Knezevic, Andrea
- Zhang, Xi-Ping
- Chen, Zhengming
- Fennell, Myles
- Garippa, Ralph
- Seshan, Venkatraman
- Stanchina, Elisa de
- Barbash, Olena
- Batlevi, Connie Lee
- Leslie, Christina S.
- Melnick, Ari M.
- Younes, Anas
- Kharas, Michael G.
- SpringerLink (Online service)
Other Objects (12)
Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy
Somatic Mitochondrial DNA Mutations in Diffuse Large B-Cell Lymphoma
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma
TP53 and p16INK4A mutations in adult-T cell leukemia/lymphoma (ATL) in Bahia (Brazil)
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
Somatic mutations altering EZH2 Tyr641 and expression of epigenetic modifications in B-cell lymphoma
Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment
Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy
Somatic Mitochondrial DNA Mutations in Diffuse Large B-Cell Lymphoma
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma
TP53 and p16INK4A mutations in adult-T cell leukemia/lymphoma (ATL) in Bahia (Brazil)
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
Somatic mutations altering EZH2 Tyr641 and expression of epigenetic modifications in B-cell lymphoma
Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment
Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy
Somatic Mitochondrial DNA Mutations in Diffuse Large B-Cell Lymphoma
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma
TP53 and p16INK4A mutations in adult-T cell leukemia/lymphoma (ATL) in Bahia (Brazil)
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
Somatic mutations altering EZH2 Tyr641 and expression of epigenetic modifications in B-cell lymphoma
Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma